Purchases and Sales Made in Q3 2023 in Vera Therapeutics, Inc. (VERA)
This table provides information about the institutional ownership of Vera Therapeutics, Inc. (VERA) during Q3 2023. The information is specifically focused on institutions that hold shares of Vera Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Metropolitan Life Insurance CO
New York, NY |
BUY
|
- |
384+ 20.34% |
$5.26K - $7.54K
|
2.27K
$52K
|
|
|
Feb 07, 2025
Q3 2023
|
Voya Investment Management LLC
Atlanta, GA |
BUY
|
- |
284+ 2.11% |
$3.89K - $5.58K
|
13.8K
$315K
|
|
|
Nov 14, 2023
Q3 2023
|
Voya Investment Management LLC
Atlanta, GA |
BUY
|
- |
284+ 2.11% |
$3.89K - $5.58K
|
13.8K
$315K
|
|
|
Nov 07, 2023
Q3 2023
|
New York State Common Retirement Fund
|
BUY
|
- |
186+ 1.68% |
$2.55K - $3.65K
|
11.2K
$257K
|
|
|
Nov 14, 2023
Q3 2023
|
Alps Advisors Inc
Denver, CO |
BUY
|
- |
175+ 0.54% |
$2.4K - $3.44K
|
32.7K
$748K
|
|
|
Nov 15, 2023
Q3 2023
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
BUY
|
- |
17+ 0.13% |
$233 - $334
|
13.6K
$310K
|
|
|
Nov 03, 2023
Q3 2023
|
Nomura Asset Management CO LTD
Tokyo, M0 |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-3.17K- 12.08% |
$43.5K - $62.3K
|
23.1K
$528K
|
|
|
Oct 24, 2023
Q3 2023
|
Raymond James & Associates
St Petersburg, FL |
SELL
|
- |
-3.5K- 10.92% |
$48K - $68.7K
|
28.5K
$653K
|
|
|
Nov 02, 2023
Q3 2023
|
Platinum Investment Management LTD
Sydney Australia 2000, C3 |
SELL
|
- |
-9.4K- 4.48% |
$129K - $185K
|
200K
$4.58M
|
|
|
Nov 14, 2023
Q3 2023
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-17.2K- 21.61% |
$236K - $337K
|
62.3K
$1.43M
|
|
|
Nov 14, 2023
Q3 2023
|
Weiss Multi Strategy Advisers LLC
New York, NY |
SELL
|
- |
-34.8K- 43.51% |
$477K - $684K
|
45.2K
$1.03M
|
|
|
Nov 14, 2023
Q3 2023
|
Kynam Capital Management, LP
Princeton, NJ |
SELL
|
- |
-43.9K- 1.46% |
$603K - $863K
|
2.96M
$67.6M
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-53.3K- 5.51% |
$731K - $1.05M
|
915K
$20.9M
|
|
|
Nov 14, 2023
Q3 2023
|
Tri Locum Partners LP
New York, NY |
SELL
|
- |
-65.5K- 60.12% |
$898K - $1.29M
|
43.4K
$994K
|
|
|
Nov 14, 2023
Q3 2023
|
Polar Asset Management Partners Inc.
Toronto, A6 |
SELL
|
- |
-127K- 48.26% |
$1.74M - $2.49M
|
136K
$3.11M
|
|
|
Nov 14, 2023
Q3 2023
|
International Biotechnology Trust PLC
London, X0 |
SELL
|
- |
-217K- 22.24% |
$2.97M - $4.26M
|
758K
$17.4M
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-229K- 35.34% |
$3.15M - $4.51M
|
420K
$9.61M
|
|
|
Nov 14, 2023
Q3 2023
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-239K- 13.59% |
$3.27M - $4.69M
|
1.52M
$34.7M
|
|
|
Nov 14, 2023
Q3 2023
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-262K- 15.08% |
$3.6M - $5.15M
|
1.48M
$33.8M
|
|
|
Nov 03, 2023
Q3 2023
|
Carlyle Group Inc.
Washington, DC |
SELL
|
- |
-979K- 40.49% |
$13.4M - $19.2M
|
1.44M
$32.9M
|